Amplification to Abbott Labs Rating on Aug. 25
Dow Jones2026/08/28 13:47TD Cowen raised its price target on Abbott Labs to $135.00/share from $115.00/share on August 21. "Abbott Labs Price Target Raised to $135.00/Share From $115.00 by TD Cowen" published at 4:57 p.m. ET on August 25, 2026 incorrectly omitted the timing of the price target change.
(END) Dow Jones Newswires
August 28, 2026 09:47 ET (13:47 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Euro drifts toward the bottom of its range as US rate bets climb
Investors reportedly offering Anthropic allocation shares at premiums of up to 5% ahead of its IPO
According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.